Navigation Links
Aeterna Zentaris Reports Third Quarter 2010 Financial and Operating Results
Date:11/9/2010

summaryInterim Consolidated Results of Operations
(in thousands, except for share and per share data)
(unaudited)

    Three months ended
September 30, Nine months ended
September 30,   2010 2009 2010 2009   $ $ $ $ Revenues Sales and royalties 5,463 5,539 16,344 15,937 License fees and other 263 3,026 1,388 7,118   5,726 8,565 17,732 23,055 Operating expenses Cost of sales, excluding depreciation and amortization 4,292 4,488 13,324 12,727 Research and development costs, net of tax credits and grants 4,061 9,738 14,791 33,251 Selling, general and administrative expenses 2,859 3,193 8,780 9,849 Depreciation and amortization   Property, plant and equipment 239 341 744 983   Intangible assets 363 594 1,110 1,714   11,814 18,354 38,749 58,524 Loss from operations (6,088) (9,789) (21,017) (35,469) Other income (expenses) Interest income 22 39 111 311 Foreign exchange (loss) gain (4,081) (1,538) 429 (1,598)   (4,059) (1,499) 540 (1,287) Net loss for the period (10,147) (11,288) (20,477) (36,756)   Net loss per share Basic and diluted (0.12) (0.19) (0.28) (0.67) Weighted average number of shares Basic and diluted 83,139,620 58,506,619 73,122,927 55,135,876 Interim Consolidated Balance Sheet Information
(in thousands)
(unaudited)   As atSeptember 30,2010 As
'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. AEterna Zentaris Announces Appointment of Prof. Jurgen Engel, Ph.D. as New President and CEO
2. AEterna Zentaris Reports Second Quarter 2008 Financial and Operating Results
3. AEterna Zentaris to Present at Upcoming CIBC World Markets 7th Annual Eastern Investor Conference
4. AEterna Zentaris to Present at BioContact Quebec on October 2, 2008
5. AEterna Zentaris Completes Patient Recruitment for Second Efficacy Trial of its Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia
6. AEterna Zentaris Receives Notification from Nasdaq Relating to Minimum Bid Price
7. AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference
8. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Endometrial Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
9. AEterna Zentaris Agrees to Sell Cetrotide(R) Royalty Stream for $52.5 Million to Cowen Healthcare Royalty Partners
10. AEterna Zentaris to Announce Third Quarter 2008 Financial and Operating Results on November 13, 2008
11. AEterna Zentaris Reports Third Quarter 2008 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... WASHINGTON , May 4, 2015   ... announced updated interim data from Tocagen,s ongoing investigational ... Satellite Symposium of the American Association of Neurological ... Tumors, held May 1-2, 2015, in ... the company held a meeting with FDA and ...
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital has ... hand impairments by acquiring the Armeo®Spring arm and ... site. , Secured through grant support of a ... option for patients with upper extremity weakness or ... of just four Illinois providers offering treatment with ...
(Date:5/1/2015)... , May 1, 2015 /PRNewswire/ - BioAmber Inc. ... sustainable chemicals, today announced that it has priced an underwritten ... at a price of $9.00 per share, and granted ... purchase up to an additional 585,000 shares of its ... be $35.1 million.  The offering is expected to close on ...
(Date:5/1/2015)... 1, 2015 A new report ... drugs will reach $22.4bn in 2019. That revenue forecast ... and Market Prospects 2015-2025 ,  published in ... is to provide forecasts and qualitative analyses of the ... and consultancy in London, UK . ...
Breaking Biology Technology:Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 2Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 4Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 5Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5
... 7 Cold season has settled in for the,winter ... cause for doctor,appointments and missed days of school and ... boost your immune system. And Immunity Enhanced Beverage is ... Recently introduced by Innovative Beverage Products, Immunity Enhanced,Beverage is ...
... Efficient Cold Chain VisibilityBEVERLY, Mass., Jan. 7 ... cold-chain visibility solutions, has launched the TempTale(R)4USB temperature ... model of the industry-leading TempTale4 product line provides ... proprietary software or readers. Sensitech is a wholly ...
... Ryan Burnette, Director of Alliance Biosciences will lead a ... 23, 2009. Dr. Burnette will be promoting the ... as a lynchpin to an effective biosecurity and biosafety ... a progressive country that has embraced the need for ...
Cached Biology Technology:Innovative Beverage Products Launches New Product Designed to Enhance the Body's Immune Defense 2Introducing Sensitech's TempTale(R)4USB Temperature Monitor 2Introducing Sensitech's TempTale(R)4USB Temperature Monitor 3Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar 2Alliance Biosciences Announces Trade Mission to Singapore with Speaker Presentation at International Lab Design Seminar 3
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... NEW YORK , March 31, 2015   ... announced the launch of the Post-Surgical Pain Management TRACKER, ... data products tracking usage trends in the medical device ... monthly access to data including treatment volumes, market share, ... manage the pain associated with joint surgery. ...
(Date:3/24/2015)... 2015   NexID Biometrics LLC, whose spoof-mitigation ... today announced the beginning of shipments of version 2.0 ... The company, based in Potsdam, N.Y. ... Expo, which began here today at the Walter E. ... of its SDK boosts the accuracy rate range to ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2
... Your primary care physician may be your first choice ... new study led by researchers at the Johns Hopkins ... they may not be the best health care professionals ... physician perspectives on the causes of and solutions to ...
... their songs, most often heard in breeding season when males ... reports of whale songs occurring outside traditional breeding grounds have ... why. Humpbacks sing for their supper -- or ... The research, published December 19 in PLoS ONE , ...
... and you,re likely to see the dispersal of seedsdandelion tufts ... flying off with a dogwood fruit. You might even have ... recent graduate of the Virginia Institute of Marine Science, has ... environmentthe eelgrass beds of Chesapeake Bay. The studythe first to ...
Cached Biology News:Physicians admit feeling under qualified and lacking necessary education to treat obesity 2Multi-tasking whales sing while feeding, not just breeding 2Study reveals that animals contribute to seagrass dispersal 2Study reveals that animals contribute to seagrass dispersal 3
streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
Template and primers for preparation of internal control spots...
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
Reusble. Uses in conjunction with the Apoptotic Cell Isolation Kit....
Biology Products: